RxDoctor Payments Data

John Capo, MD

Hand Surgery · Jersey City, NJNPI 1982781209

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,062,802 of the $1,130,981 with a category attached, or 94.0%. Alcon Research LLC accounts for 94.0% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2019 at $1,099,237 and has fallen 99.7% since, to $3,182 in 2025. Among hand surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,130,981in general payments, 2019–2025

Across 93 payments — averaging $12,161 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon Research LLC$1.1M
  • Axogen$29K
  • Synthes GmbH$18K
  • Medical Device Business Services, Inc.$11K
  • Synthes USA Products LLC$6K
  • Skeletal Dynamics Inc$2K
  • plus $3K from 22 others

What the payments were for

  • Royalty or licence$1,062,80294%
  • Consulting fees$18,8922%
  • Speaking & faculty fees$36,7903%
  • Travel & lodging$8,5521%
  • Food & beverage$3,9440%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,130,981 in reported general payments places this provider in the 95th percentile of 87 hand surgery providers in New Jersey.

See all hand surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$35,800
Medicare patients
95
Services billed
1,302

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naproxen208$2,355
Diclofenac Sodium73$1,917
Meloxicam19$44

Paid to pharmacies, not to this prescriber.

Other hand surgery in Jersey City

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →